Maryland company believes it has cure for HIV/AIDS

By AGT | Nov 8, 2019
Filed Under:

Published by:  Written by: Janay Parrott ROCKVILLE, Md. (WDVM) – Wednesday night was an exciting one for investors and employees at American Gene Technologies. After years in the making, they submitted a nearly 1,000-page document to FDA. And within its pages just may lie the cure for HIV/AIDS. American… [Read More]

Gene Therapy Targets Aids

By AGT | Sep 12, 2019
Filed Under:

Published by: BiotechPrimer  Written by: Emily Burke, PhD For many years, a diagnosis of acquired immunodeficiency syndrome (AIDS) was a death sentence. It seemed unthinkable in the 1980s, but the medical community now largely treats the disease as a chronic illness. This profound shift arose through the development of highly active… [Read More]

The Gene Fix That Might Cure HIV

By AGT | Sep 6, 2019
Filed Under:

Published by:  One Zero  Written by:  Emily Mullin Antiretroviral drugs make HIV manageable, but gene therapies could eliminate the virus altogether — provided the treatments can be made safe and economical In the mid-1990s, scientists made a curious but remarkable discovery: A man named Stephen Crohn seemed virtually immune to HIV. In… [Read More]

Montgomery Magazine: “Jeffrey Galvin’s BioTech Firm May Be on The Verge of Curing HIV/AIDS”

By AGT | Aug 19, 2019
Filed Under:

Published by: Montgomery Magazine  | Issue:  August – September 2019, Page 42 Written by: Jeff Thoreson | Photograph by: Kevin Allen A 3D RENDERING OF HIV VIRUS IN BLOOD STREAM Jeffrey Galvin has been a computer nerd since the seventh grade. Way back in the 1970s era of mainframes, he… [Read More]

C&EN: “How Phenylketonuria, A Once-Neglected Disease, Became A Proving Ground For New Drugs”

By AGT | Jul 9, 2019
Filed Under:

Published by: C&EN on May 12, 2019, In: Volume 97, Issue 27.  Written by: Ryan Cross After decades of yearning for drugs, people with PKU now have 2, and a dozen more are in development. It’s dinnertime on a Wednesday evening in June at the Wards’ house in Whitman, Massachusetts…. [Read More]

C&EN: “With Several Long-acting HIV Treatments In The Works, The Newest Drugs Emphasize Convenience”

By AGT | Jun 18, 2019
Filed Under:

Published by: C&EN on May 12, 2019, In Volume 97, Issue 19.  Written by: Megha Satyanarayana Lionel Hillard’s boss asked him to come into his office. It was the late 1980s in Dallas. The then 29-year-old was a medical assistant at a busy clinic with a room full of patients…. [Read More]

Site Selection: “The Future of Healthcare is Here: Maryland Leads a Biotech Revolution”

By AGT | Jun 17, 2019
Filed Under:

Published by: Site Selection, Digital Edition, May 2019 Issue.  Written by: Gary Daughters Jeff Galvin, founder and CEO of Rockville, Maryland’s American Gene Technologies, speaks of cellular gene therapy with the zeal of an evangelist. “I believe we’re on the eve of a gene and cell therapy revolution that will… [Read More]

Washington Post: “New CDC Chief Stepped Down From Four Groups to Comply With Ethics Rules”

By AGT | Jun 5, 2019
Filed Under:

Published by: The Washington Post.  Written by: Lena H. Sun Centers for Disease Control and Prevention Director Robert Redfield has resigned his  positions at four groups, including a gene therapy biotechnology company and a conservative AIDS organization, to comply with government ethics rules, according to his financial disclosures. Redfield, a longtime… [Read More]

Wall Street Journal: “New CDC Chief Resigned From Four Entities to Comply With Ethics Rules”

By AGT | Jun 1, 2019
Filed Under:

Published by: The Wall Street Journal.  Written by: Betsy McKay Updated: April 17, 2018 11:09 am ET Financial disclosures detail steps Robert Redfield has taken; ethics office found him to be in compliance The new director of the Centers for Disease Control and Prevention resigned positions at four entities, sold… [Read More]

BioWorld Reports American Gene Technologies’s Progress Toward an HIV cure

By AGT | Jan 31, 2018
Filed Under:

Newsletter Vol. 29, No. 18, Pg. 2 January 26, 2018 On January 26, 2018, BioWorld, The Daily Biopharmaceutical Newscource, published this story:   American Gene Technologies International Inc. (AGT), of Rockville, Md., disclosed completion of the pilot runs of its HIV cure automated cell processing protocol. That completes a key… [Read More]

Subscribe to Our Newsletter

Subscribe to our newsletter to keep up to date with all the latest news about AGT!

Mailchimp sidebar

Follow AGT on Social Media

Send this to a friend